ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Overweight

Diabetes trials near Warszawa, Mazowieckie, POL:

Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity (SINT1A)

months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...

Active, not recruiting
Diabetes Mellitus, Type 1
Dietary Supplement: Placebo
Dietary Supplement: B. infantis
Helmholtz Zentrum München

Warsaw, Poland and 7 other locations

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Warsaw, Poland and 59 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Warsaw, Mazowieckie, Poland and 654 other locations

evaluate the efficacy, safety and pharmacokinetic (PK) properties of CPL207280 after multiple (14 days) administration in patients with type 2 diabetes...

Enrolling
Type 2 Diabetes
Drug: Placebo
Drug: CPL207280

Phase 2

Celon Pharma

Kajetany, Nadarzyn, Poland

The primary purpose of this study is to evaluate the efficacy of medical cannabis aerosol containing 0.25, 0.5, 1.0 milligrams (mg) delta (Δ)9-tetrah...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Medical Cannabis
Drug: Placebo

Phase 2

Syqe Medical

Warszawa, Mazowieckie, Poland and 21 other locations

levels when given along with semaglutide in patients with type 2 diabetes. Participants will get the medicine insulin icodec once a week in ...

Enrolling
Diabetes Mellitus, Type 2
Drug: Insulin Icodec
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Mazowieckie, Poland and 32 other locations

as insulin glargine in this form) taken daily in people with type 2 diabetes. The study will look at how well IcoSema controls blood sugar l...

Active, not recruiting
Type 2 Diabetes
Drug: IcoSema
Drug: Insulin glargine

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 90 other locations

The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes...

Not yet enrolling
Type 2 Diabetes
Drug: LY3457263
Drug: Placebo

Phase 2

Lilly
Lilly

Warszawa, Mazowieckie, Poland and 55 other locations

This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...

Active, not recruiting
Type 2 Diabetes Mellitus
Biological: Insulin
Drug: Placebo to ertugliflozin 5 mg

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Warszawa, Mazowieckie, Poland and 103 other locations

This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a n...

Active, not recruiting
Type 2 Diabetes
Drug: Semaglutide
Drug: Placebo

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 48 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems